
Jim McKelvey talks Square Inc, FDA Fast Trials & the Fed
Ted Hesser Podcast
00:00
Navigating Healthcare Innovations and Challenges
This chapter explores the intricacies of Baumol's cost disease within the healthcare and education sectors, highlighting the challenges of rising costs despite minimal productivity gains. It discusses the impact of AI on job roles and the urgent need for innovative solutions to expedite drug trials and regulatory processes, emphasizing efforts like the establishment of Fast Trials. Additionally, the chapter addresses the dangers of unverified health products and advocates for rigorous scientific validation to ensure the safety and effectiveness of new treatments.
Transcript
Play full episode